Market Research Logo

Angiotensin Converting Enzymes (ACE) Inhibitors Market - Report Analysis till 2026

Angiotensin Converting Enzymes (ACE) Inhibitors Market - Report Analysis till 2026

Angiotensin converting enzymes (ACE) inhibitors act by inhibiting the angiotensin converting enzyme (ACE), which is an important component of renin angiotensin system. ACE inhibitors reduce the formation of angiotensin II and facilitate the dilation of blood vessels as well as reduce blood pressure. Angiotensin converting enzyme inhibitors also reduce blood pressure in kidneys. Angiotensin converting enzymes inhibitors (ACE) are effective for the treatment of congestive heart failure, stroke, and high blood pressure. However, overdose of ACE inhibitors may cause kidney failure, allergic reactions, angioedema, and neutropenia.

Market Dynamics

Increasing research and development activities related to study of ACE inhibitors is expected to boost the angiotensin converting enzymes (ACE) inhibitors market growth. For instance, in February 2016, Monia Lorini, in collaboration with Istituto Di Ricerche Farmacologiche Mario Negri initiated clinical phase II study of ACE inhibitors (Lisinopril) for the treatment of extracapillary glomerulonephritis. This study is for evaluating drug safety and efficacy on the patients. It is expected to complete in December 2019.

Furthermore, in June 2014, Cardiology Research UBC initiated clinical trial phase IV to study the effects of statin including Rosuvastatin and Ramipril - angiotensin converting enzymes inhibitors such as Ramipril on coronary flow reserve and microcirculatory resistance in patients with coronary artery dissection. This study is expected to complete in June 2021.

Overdose of angiotensin converting enzyme (ACE) inhibitors is a major factor restraining growth of the ACE inhibitors market. Overdose of ACE inhibitors may lead to various side effects such as dry cough, hyperkalemia (increased blood potassium level), dizziness, headache, and fatigue. Overdose of ACE inhibitors may also cause cancer. For instance, in October 2018, according to Medical Press (medical center in Melbourne, Australia), angiotensin converting enzymes (ACE) inhibitors are used for the treatment of high blood pressure. However, overdose of ACE inhibitors can increases the risk of lung cancer in patients. These drugs are responsible for the excessive production of bradykinin in the lungs. Excessive bradykinin is the main cause of lung cancer.

Key features of the study:

  • This report provides in-depth analysis of the angiotensin converting enzymes (ACE) inhibitors market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global angiotensin converting enzymes (ACE) inhibitors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Pfizer, Inc., AstraZeneca, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Merck KGaA, Takeda Pharmaceutical Company and Bayer AG.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global angiotensin converting enzymes (ACE) inhibitors market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for angiotensin converting enzymes (ACE) inhibitors market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Application:
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Angiotensin Converting Enzymes (ACE) Inhibitors market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney diseases
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application:
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application:
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Drugs:
  • Benazepril
  • Perindopril
  • Trandolapril
  • Captopril
  • Enalaopril
  • Lisinopril
  • Ramipril
  • Others
  • By Application:
  • Hypertension
  • Coronary artery disease
  • Heart failure
  • Chronic kidney disease
  • Scleroderma
  • Migraine
  • By Distribution Channels:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • AstraZeneca Pharmaceutical Company
  • Novartis AG
  • Daiichi Sankyo Company, Ltd.
  • United Therapeutics Corporation
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Takeda Pharmaceutical Company
  • Bayer AG
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drugs
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Epidemiology
Historical Overview
Merger and Acquisition
Regulatory Scenario
PEST Analysis
4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market, By Drugs, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Benazepril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Perindopril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Trandolapril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Captopril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Enalaopril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Lisinopril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Ramipril
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Application, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Coronary artery disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Heart failure
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Chronic kidney disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Scleroderma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Migraine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Distribution Channel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channels, 2016 – 2026, (US$ Million
Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drugs, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AstraZeneca Pharmaceutical Company
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Daiichi Sankyo Company, Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
United Therapeutics Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Johnson & Johnson Services, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck KGaA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Takeda Pharmaceutical Company
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bayer AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 29 market data tables and 25 figures on “Angiotensin Converting Enzymes (ACE) Inhibitors Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report